Annal D. Meleth - Concepedia

Author

Annal D. Meleth

National Institutes of Health ORCID

Also Known As

A Dhananjayan Meleth, A. D. Meleth, Annal D Meleth, Annal D. Meleth, Annal Dhananjayan Meleth, Annal Meleth

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Eye Institute Elman Retina Group Emmes (United States)Stanford University

About

Annal D. Meleth is an author at National Institutes of Health specializing in ophthalmology, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	342
2	Public Health	3	3	409
3	Health Sciences	1	1	178
4	Cell Biology	1	1	213
5	Epidemiology	1	1	178

Annal D. Meleth

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Serum Inflammatory Markers in Diabetic Retinopathy Annal D. Meleth, Elvira Agro ́n, Chi‐Chao Chan, Investigative Ophthalmology & Visual Science	2005	283
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration Jingsheng Tuo, Brena C. Smith, Christine M. Bojanowski, The FASEB Journal Ocular DiseaseAge‐related Macular DegenerationOphthalmologySequence VariationSequence Variation/expression	2004	213
Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes Michael Cusick, Annal D. Meleth, Elvira Agrón, Diabetes Care	2005	191
ω–3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study John Paul SanGiovanni, Elvira Agrón, Annal D. Meleth, American Journal of Clinical Nutrition Metabolic SyndromeOcular DiseaseAgingOphthalmologyCardiometabolic Risk	2009	178
Changes in Retinal Sensitivity in Geographic Atrophy Progression as Measured by Microperimetry Annal D. Meleth, Pradeep Mettu, Elvira Agrón, Investigative Ophthalmology & Visual Science	2010	112
Rapid Upregulation of α7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation Chang-Hoon Cho, Weifeng Song, Katherine Leitzell, Journal of Neuroscience	2005	87
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial David M. Brown, David S. Boyer, V. Diana, The Lancet Diabetic RetinopathyOcular DiseaseOphthalmologyExperimental OphthalmologyDiabetic Macular Oedema	2024	78
FINASTERIDE FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY Farzin Forooghian, Annal D. Meleth, Catherine A. Cukras, Retina	2011	73
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy Raj K. Maturi, Adam R. Glassman, Kristin Josic, JAMA	2023	53
Subconjunctival Sirolimus for the Treatment of Chronic Active Anterior Uveitis: Results of a Pilot Trial H. Nida Sen, Theresa A. Larson, Annal D. Meleth, American Journal of Ophthalmology Pilot TrialOphthalmologySurgeryGlaucomaSubconjunctival Sirolimus	2012	33

Page 1